Company news

Eyebright Medical Technology (Beijing) Co., Ltd. news in 2025

Eyebright Medical Technology (Beijing) Co., Ltd.'s news releases, calls and decks from 2025, newest first.

View company

Announcement on Convening the Q3 2025 Performance Briefing

November 20, 2025

Announcement on Circulation of Restricted Shares Issued to Specific Objects by Simplified Procedure

November 4, 2025

Report for Q3 2025

October 29, 2025

Announcement on Voluntary Disclosure of Approval for Market Launch of the Extended Depth-of-Focus Intraocular Lens (EDOF IOL) Through the Special Review Process for Innovative Medical Devices

September 26, 2025

Announcement on the Result of Shareholding Reduction by Shareholder and Equity Change Reaching the 1% Scale

September 4, 2025

Announcement on Convening the 2025 Semi-annual Performance Briefing

August 27, 2025

Indicative Announcement on Change in Equity of Shareholders with Over 5% Shares Reaching 1%

August 7, 2025

Announcement on Implementation of Dividend Distribution for 2024

July 11, 2025

Announcement on Adjusting Total Cash Dividends for 2024 Annual Profit Distribution

June 27, 2025

Announcement on Changing Registered Capital, Amending the Articles of Association, and Handling Industrial and Commercial Change Registration

June 19, 2025

Announcement on Share Reduction Plan for Shareholders

June 3, 2025

Announcement on Cancellation of Some Restricted Stocks Granted yet Unvested in 2021 Restricted Stock Incentive Plan

May 29, 2025

Announcement on Results of Issuing Shares to Specific Objects by Summary Procedure and Changes in Capital Stock in 2024

May 13, 2025

Announcement on Signing Three-party and Four-party Supervision Agreements for Deposit of Raised Fund in Special Account

May 6, 2025

Eyebright Medical Published its 2024 Environmental, Social and Governance Report

April 22, 2025

Announcement on Convening the 2024 Annual and Q1 2025 Performance Briefing

April 16, 2025

Announcement on Approval of Application for Issuance of Shares to Specific Objects via Summary Procedure by the Shanghai Stock Exchange in 2024

March 12, 2025

Announcement on the Expiry of Planned Time for Shareholders with Over 5% Shares to Reduce Shares and Results of Share Reduction

March 10, 2025

Announcement on the Acceptance of Application for Issuance of Shares to Specific Objects via Summary Procedure by the Shanghai Stock Exchange

February 28, 2025

Announcement on Diluted Immediate Return, Remedial Measures, and Related Entity Commitments for Issuance of Shares to Specific Objects by Summary Procedure (Second Revised)

February 25, 2025

Announcement on the Release of Pledge of Shares by Shareholders

February 12, 2025

Announcement on Implementation Results of Share Repurchase

February 6, 2025

Announcement on the Voluntary Disclosure of the Phakic Intraocular Lens Being Approved for Marketing through the Special Review Procedure for Innovative Medical Devices

January 7, 2025

Announcement on Progress in Repurchasing Shares through Call Auction

January 3, 2025